Cargando…

Retraction: Inhibitor 9 Combined With Androgen Deprivation Therapy or Chemotherapy Delays the Malignant Behavior of Castration-Resistant Prostate Cancer Through K-Ras/PLCϵ/PKCϵ Signaling Pathway

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202285/ https://www.ncbi.nlm.nih.gov/pubmed/34136414 http://dx.doi.org/10.3389/fonc.2021.707608

Ejemplares similares

Inhibitor 9 Combined With Androgen Deprivation Therapy or Chemotherapy Delays the Malignant Behavior of Castration-Resistant Prostate Cancer Through K-Ras/PLCε/PKCε Signaling Pathway
por: Liu, Jiayu, et al.
Publicado: (2020)

Metformin mitigates PLCε gene expression and modulates the Notch1/Hes and androgen receptor signaling pathways in castration-resistant prostate cancer xenograft models
por: Li, Qi, et al.
Publicado: (2021)

PLCε knockdown enhances the radiosensitivity of castration-resistant prostate cancer via the AR/PARP1/DNA-PKcs axis
por: Pu, Jun, et al.
Publicado: (2020)

PLCε knockdown enhances the radiosensitivity of castration-resistant prostate cancer via the AR/PARP1/DNA-PKcs axis
por: Pu, Jun, et al.
Publicado: (2022)

Kinetics of PKCε Activating and Inhibiting Llama Single Chain Antibodies and Their Effect on PKCε Translocation in HeLa Cells
por: Summanen, Milla, et al.
Publicado: (2012)

COX-2 MEDIATES PRO-TUMORIGENIC EFFECTS OF PKCε IN PROSTATE CANCER
por: Garg, Rachana, et al.
Publicado: (2018)

Impact of PKCε downregulation on autophagy in glioblastoma cells
por: Toton, Ewa, et al.
Publicado: (2018)

Differential Roles of the PKC Novel Isoforms, PKCδ and PKCε, in Mouse and Human Platelets
por: Pears, Catherine J., et al.
Publicado: (2008)

PLCε regulates prostate cancer mitochondrial oxidative metabolism and migration via upregulation of Twist1
por: Fan, Jiaxin, et al.
Publicado: (2019)

Tissue-specific conditional PKCε knockout mice: a model to precisely reveal PKCε functional role in initiation, promotion and progression of cancer
por: Hafeez, Bilal Bin, et al.
Publicado: (2016)

PKCε Activation Restores Loss of PKCε, Manganese Superoxide Dismutase, Vascular Endothelial Growth Factor, and Microvessels in Aged and Alzheimer’s Disease Hippocampus
por: Millien, Guetchyn, et al.
Publicado: (2022)

The controversial role of phospholipase C epsilon (PLCε) in cancer development and progression
por: Tyutyunnykova, Anna, et al.
Publicado: (2017)

Surgical castration efficiently delays the time of starting a systemic chemotherapy in castration-resistant prostate cancer patients refractory to initial androgen-deprivation therapy
por: Kang, Minyong, et al.
Publicado: (2015)

Ethanol-Induced Changes in PKCε: From Cell to Behavior
por: Pakri Mohamed, Rashidi M., et al.
Publicado: (2018)

Mechanism of PKCε regulation of cardiac GIRK channel gating
por: Gada, Kirin D., et al.
Publicado: (2022)

Exploring the prognostic significance of PKCε variants in cervical cancer
por: Zafar, Sameen, et al.
Publicado: (2023)

PKCε Phosphorylates and Mediates the Cell Membrane Localization of RhoA
por: Su, Tizhi, et al.
Publicado: (2013)

Mitotic catenation is monitored and resolved by a PKCε-regulated pathway
por: Brownlow, Nicola, et al.
Publicado: (2014)

IKKε inhibits PKC to promote Fascin-dependent actin bundling
por: Otani, Tetsuhisa, et al.
Publicado: (2016)

A cancer-associated, genome protective programme engaging PKCε
por: Parker, Peter J., et al.
Publicado: (2020)

Correction: Exploring the prognostic significance of PKCε variants in cervical cancer
por: Zafar, Sameen, et al.
Publicado: (2023)

Combination of phospholipase Cε knockdown with GANT61 sensitizes castration-resistant prostate cancer cells to enzalutamide by suppressing the androgen receptor signaling pathway
por: Sun, Wei, et al.
Publicado: (2019)

Combination of phospholipase Cε knockdown with GANT61 sensitizes castration-resistant prostate cancer cells to enzalutamide by suppressing the androgen receptor signaling pathway
por: Sun, Wei, et al.
Publicado: (2022)

Thienoquinolines as Novel Disruptors of the PKCε/RACK2 Protein–Protein Interaction
por: Rechfeld, Florian, et al.
Publicado: (2014)

PKCε and allopregnanolone: functional cross-talk at the GABA(A) receptor level
por: Puia, Giulia, et al.
Publicado: (2015)

PKCε stimulation of TRPV1 orchestrates carotid body responses to asthmakines
por: Jendzjowsky, Nicholas G., et al.
Publicado: (2020)

ε2 allele and ε2-involved genotypes (ε2/ε2, ε2/ε3, and ε2/ε4) may confer the association of APOE genetic polymorphism with risks of nephropathy in type 2 diabetes: a meta-analysis
por: Shi, Jikang, et al.
Publicado: (2020)

Targeting IKKε in Androgen-Independent Prostate Cancer Causes Phenotypic Senescence and Genomic Instability
por: Gilbert, Sophie, et al.
Publicado: (2022)

Efficacy of Androgen Deprivation Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Docetaxel-Based Chemotherapy
por: Min, Kyungchan, et al.
Publicado: (2020)

Aldehyde dehydrogenase 2 activation and coevolution of its εPKC-mediated phosphorylation sites
por: Nene, Aishwarya, et al.
Publicado: (2017)

Involvement of PKCε in FSH-induced connexin43 phosphorylation and oocyte maturation in mouse
por: Cai, Han, et al.
Publicado: (2018)

Phosphorylation of glutaminase by PKCε is essential for its enzymatic activity and critically contributes to tumorigenesis
por: Han, Tianyu, et al.
Publicado: (2018)

PKCε phosphorylation regulates the mitochondrial translocation of ATF2 in ischemia-induced neurodegeneration
por: Kumar, Varun, et al.
Publicado: (2018)

Role of PKCε in the epithelial-mesenchymal transition induced by FGFR2 isoform switch
por: Ranieri, Danilo, et al.
Publicado: (2020)

Persistent androgen receptor-mediated transcription in castration-resistant prostate cancer under androgen-deprived conditions
por: Decker, Keith F., et al.
Publicado: (2012)

Dataset of bond enthalpies (ε(AA), ε(AB), ε(BB)) in 975 binary intermetallic compounds
por: Miracle, Daniel, et al.
Publicado: (2021)

Opposed Actions of PKA Isozymes (RI and RII) and PKC Isoforms (cPKCβI and nPKCε) in Neuromuscular Developmental Synapse Elimination
por: Garcia, Neus, et al.
Publicado: (2019)

CPT1A Supports Castration-Resistant Prostate Cancer in Androgen-Deprived Conditions
por: Joshi, Molishree, et al.
Publicado: (2019)

Androgen deprivation-induced OPHN1 amplification promotes castration-resistant prostate cancer
por: Liu, Junjiang, et al.
Publicado: (2022)

Reversing the effects of androgen-deprivation therapy in men with metastatic castration-resistant prostate cancer
por: Marshall, Catherine H., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4lk8vufjfk3v3olcmmt6gt50h1